Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01748565 · ClinicalTrials.gov registry record
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 260
- Enrollment target
NCT01748565: Completed study, sponsored by Duke University.
NCT01748565 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 260 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01748565 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
The purpose of this study is to identify biological markers that might predict premature infants who are at a higher risk for developing BPD, and to correlate the presence of these markers with infant symptoms and lung function in the first year after discharge from the hospital.
Primary Outcome
Comparing urine GRP levels to urine biomarkers of oxidative stress in infants with and without BPD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-08 |
What the finished NCT01748565 record still lists
NCT01748565 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01748565 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01748565 about?
NCT01748565 is a clinical study titled "Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia". The purpose of this study is to identify biological markers that might predict premature infants who are at a higher risk for developing BPD, and to correlate the presence of these markers with infant symptoms and lung function in the first year after discharge from the hospital.
What is the current status of trial NCT01748565?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2012-05. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT01748565?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia